Market Overview

Blueprint Medicines (NYSE: BPMC)

77.71 +0.44 (0.57%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/15/19ReinstatesMarket Perform
7/19/19Initiates Coverage OnOutperform120.0
7/18/19Initiates Coverage OnBuy110.0
5/23/19AssumesBuy125.0
4/03/19Initiates Coverage OnOverweight112.0
9/25/18Initiates Coverage OnOutperform105.0
6/04/18MaintainsMarket Outperform103.0
4/16/18MaintainsOutperform106.0
10/23/17MaintainsOverweight78.0
9/29/17Initiates Coverage OnBuy90.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter